Navigation Links
Ensil Canada Announces First Successful Test and Validation of Vastusys Line of Products in Ontario Laboratories

MARKHAM, Ontario, July 11, 2013 /PRNewswire/ -- This morning Ensil Canada announced the exciting news that its scientific team of researchers and engineers have made a major breakthrough in the development of a revolutionary medical product that has the potential to help patients who suffer from mobility issues.

Ensil Canada has completed successful test results that show a proprietary communication device can be used to communicate with the brain and bypass the spine. This breakthrough meets the targets set by Ensil to have a prototype of a device by the end of 2013 for more comprehensive testing.

"We are very proud and confident that we have developed a product at our Ontario, Canada facilities that could help tens of thousands of people who suffer from mobility issues," said Farsad Kiani, CEO of Ensil Canada. "This is a phenomenal first step. It is our hope that we can bring this product to market, so that people can continue enjoying their day to day activities such as jogging, swimming and walking."

Today's announcement is one of the many areas of research by Ensil Canada to improve the lives of people across the world. Over the past three decades, Ensil Canada has made many positive breakthroughs and worked in the community to improve people's health and wellbeing. Recent work has included major advancements in the quality of the life of those whose their life has been affected by Stroke, Multiple Scoliosis, Spinal Cord injury or paralysis.

Ensil Canada focuses on enhancing mission critical technologies in the areas of Aerospace, Defence and Medical Diagnostic Equipment. Ensil's research and development divisions' mission is to develop new technologies or improve existing technologies through its own in-house research activities and resources.

Ensil Canada, a member of Ensil group of companies (, focuses on enhancing mission critical technologies in the areas of aerospace, defence, telecommunication and medical diagnostic equipment.

Ensil's R&D divisions' mission is to develop new technologies or improve existing technologies through in-house research activities.

For further information please contact us at: info or visit us at

This press release was issued through  For further information, visit

SOURCE Ensil Canada Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. scPharmaceuticals LLC Announces Strategic Partnership with Sensile Medical to Develop Novel Heart Failure Treatment Aimed to Reduce Readmission Rates
2. Canada-based Radimetrics Announces Expansion to Scotland
3. Fidelitas Launches Unique Methadone Documentation and Dispensing System in Canada
4. Ampio Advances NCE001 Cancer Drug into Preclinical Development Following Successful Recent Financing and the Granting of Patents in USA, Canada, Europe and China
5. Award-Winning Spot Vision Screener To Be Demonstrated At USA/Canada Lions Leadership Forum
6. VirtualScopics Receives Issuance of Influential Patent in Canada
7. VisionCare Receives Health Canada License for First-Ever Telescope Prosthesis for End-Stage Macular Degeneration
8. Daniels Sharpsmart Canada Awarded HealthPro Contract And Appoints Daniel Kennedy CEO Of Daniels Canada
9. Sensus Healthcare Announces Health Canada Approval
10. New Treatment For Obstructive Sleep Apnea Now Available In Canada
11. Integrated Marketing Company Expands Into Canada
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016 Research ... World Market for Companion Diagnostic Tests" report to their ... Market for Companion Diagnostics The World Market ... and personalized medicine diagnostics. Market analysis in the report includes ... Test Market (In Vitro Diagnostic Kits) by Region (N. America, ...
(Date:6/23/2016)... -- MedSource announced today that it has selected Datatrial,s ... choice.  This latest decision demonstrates MedSource,s commitment to ... by offering a state-of-the-art electronic data capture (EDC) ... the EDC platform of choice in exchange for ... long been a preferred EDC platform by our ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic ... World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. ... some of the world’s leading providers of cereal and other breakfast foods. Its residents ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... PawPaws ... a new product that was developed to enhance the health of felines. The formula ... , The two main herbs in the PawPaws Cat Kidney Support Supplement ...
(Date:6/26/2016)... Birmingham, Lake Orion, Clarkston, Michigan (PRWEB) , ... ... ... their direction with respect to fertility once they have been diagnosed with endometriosis. ... for tolerable intercourse but they also require a comprehensive approach that can help ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, ... Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms ... Final Cut Pro X . Simply select a ProHand generator and drag it above ...
Breaking Medicine News(10 mins):